These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25939331)

  • 1. Concise and Practical Asymmetric Synthesis of a Challenging Atropisomeric HIV Integrase Inhibitor.
    Fandrick KR; Li W; Zhang Y; Tang W; Gao J; Rodriguez S; Patel ND; Reeves DC; Wu JP; Sanyal S; Gonnella N; Qu B; Haddad N; Lorenz JC; Sidhu K; Wang J; Ma S; Grinberg N; Lee H; Tsantrizos Y; Poupart MA; Busacca CA; Yee NK; Lu BZ; Senanayake CH
    Angew Chem Int Ed Engl; 2015 Jun; 54(24):7144-8. PubMed ID: 25939331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic asymmetric synthesis of an HIV integrase inhibitor.
    Zhong YL; Krska SW; Zhou H; Reamer RA; Lee J; Sun Y; Askin D
    Org Lett; 2009 Jan; 11(2):369-72. PubMed ID: 19099496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
    Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X
    Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity.
    Li H; Wang C; Sanchez T; Tan Y; Jiang C; Neamati N; Zhao G
    Bioorg Med Chem; 2009 Apr; 17(7):2913-9. PubMed ID: 19269185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
    Wang P; Liu C; Sanches T; Zhong Y; Liu B; Xiong J; Neamati N; Zhao G
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4574-8. PubMed ID: 19625188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
    J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete absolute configuration of integramide A, a natural, 16-mer peptide inhibitor of HIV-1 integrase, elucidated by total synthesis.
    De Zotti M; Formaggio F; Kaptein B; Broxterman QB; Felock PJ; Hazuda DJ; Singh SB; Brückner H; Toniolo C
    Chembiochem; 2009 Jan; 10(1):87-90. PubMed ID: 18850604
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.
    Wang Z; Vince R
    Bioorg Med Chem; 2008 Apr; 16(7):3587-95. PubMed ID: 18314335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
    Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric Synthesis of a Potent HIV-1 Integrase Inhibitor.
    Kuethe JT; Humphrey GR; Journet M; Peng Z; Childers KG
    J Org Chem; 2016 Nov; 81(21):10256-10265. PubMed ID: 27471910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors.
    Naidu BN; Sorenson ME; Patel M; Ueda Y; Banville J; Beaulieu F; Bollini S; Dicker IB; Higley H; Lin Z; Pajor L; Parker DD; Terry BJ; Zheng M; Martel A; Meanwell NA; Krystal M; Walker MA
    Bioorg Med Chem Lett; 2015 Feb; 25(3):717-20. PubMed ID: 25529736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors.
    Langford HM; Williams PD; Homnick CF; Vacca JP; Felock PJ; Stillmock KA; Witmer MV; Hazuda DJ; Gabryelski LJ; Schleif WA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):721-5. PubMed ID: 18078751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor.
    Yang L; Xu X; Huang Y; Zhang B; Zeng C; He H; Wang C; Hu L
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5469-71. PubMed ID: 20709544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action.
    Ferro S; De Luca L; Barreca ML; De Grazia S; Christ F; Debyser Z; Chimirri A
    Bioorg Med Chem; 2010 Aug; 18(15):5510-8. PubMed ID: 20630765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of novel diketoacid-containing ferrocene inhibitors of HIV-1 integrase.
    da Silva CH; Del Ponte G; Neto AF; Taft CA
    Bioorg Chem; 2005 Aug; 33(4):274-84. PubMed ID: 16023487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
    Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
    Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors.
    Gupta P; Roy N; Garg P
    Eur J Med Chem; 2009 Nov; 44(11):4276-87. PubMed ID: 19647906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.